ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
Endovia Health Sciences Inc
0.2492
+0.0052
2.13%
盤後:
0.2494
0.0002
+0.08%
19:35 EDT
成交量:
24.94萬
成交額:
6.23萬
市值:
157.00萬
市盈率:
-0.02
高:
0.2638
開:
0.2489
低:
0.2400
收:
0.2440
52周最高:
13.40
52周最低:
0.2325
股本:
630.00萬
流通股本:
629.95萬
量比:
1.47
換手率:
3.96%
股息:
- -
股息率:
- -
每股收益(TTM):
-13.6011
每股收益(LYR):
-70.9984
淨資產收益率:
--
總資產收益率:
-77.70%
市淨率:
-0.10
市盈率(LYR):
0.00
資料載入中...
總覽
公司
新聞
公告
公司資料
公司名字:
Endovia Health Sciences Inc
交易所:
AMEX
成立時間:
- -
員工人數:
2
公司地址:
1112 N. Flagler Drive,Fort Lauderdale,Florida,United States
官網:
http://endoviasciences.com
郵編:
33304
電話:
(954) 999-5446
傳真:
- -
簡介:
Endovia Health Sciences, Inc.於1992年9月3日在俄亥俄州註冊成立,並於2012年4月18日將住所變更為科羅拉多州。2021年11月8日,該公司將註冊州從科羅拉多州變更為內華達州。Endovia Health正在優先努力建立一個基於大麻素的多元化健康科學平台,專註於在製藥、獸醫和消費者健康市場獲取、開發和商業化基於大麻素的差異化健康技術。該公司的戰略結合了國際醫藥商業化、FDA監管的人類和獸醫開發以及基於大麻素的消費者健康和飲料機會。
董事
名稱
職位
Brady Cobb
Director and Interim Chief Executive Officer
Frederick William Caple
Chairman of the Board and Director
Francis Knuettel II
Director
Thomas Fore
Director
股東
名稱
職位
Brady Cobb
Director and Interim Chief Executive Officer
Michael Bondurant
Interim Chief Operating Officer
Martin Scott
Interim Chief Financial Officer
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投,即時串流報價與多種工具,立即開戶享更多優惠!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/EDVA/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"EDVA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EDVA\",,,,,undefined,":{"symbol":"EDVA","market":"US","secType":"STK","nameCN":"Endovia Health Sciences Inc","latestPrice":0.2492,"timestamp":1789156800000,"preClose":0.244,"halted":0,"volume":249438,"hourTrading":{"tag":"盘后","latestPrice":0.2494,"preClose":0.2492,"latestTime":"19:35 EDT","volume":2215,"amount":555.8122,"timestamp":1789169702004,"change":0.0002,"changeRate":0.000803,"amplitude":0.003612},"delay":0,"changeRate":0.02131147540983611,"floatShares":6299531,"shares":6300000,"eps":-13.601116,"marketStatus":"休市中","change":0.0052,"latestTime":"09-11 16:00:00 EDT","open":0.24885,"high":0.263799,"low":0.24,"amount":62257.07576844,"amplitude":0.097537,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-13.601116,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":7,"adr":0,"exchange":"AMEX","adjPreClose":0.244,"preHourTrading":{"tag":"盘前","latestPrice":0.2489,"preClose":0.244,"latestTime":"09:17 EDT","volume":5802,"amount":1431.31371432,"timestamp":1789132634679,"change":0.0049,"changeRate":0.020082,"amplitude":0.103689},"postHourTrading":{"tag":"盘后","latestPrice":0.2494,"preClose":0.2492,"latestTime":"19:35 EDT","volume":2215,"amount":555.8122,"timestamp":1789169702004,"change":0.0002,"changeRate":0.000803,"amplitude":0.003612},"volumeRatio":1.4740438779640679},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"EDVA\",,,,,undefined,":{"symbol":"EDVA","floatShares":6299531,"roa":"-77.70%","roe":"--","lyrEps":-70.998368,"volumeRatio":1.4740438779640679,"shares":6300000,"dividePrice":0,"high":0.263799,"amplitude":0.097537,"preClose":0.244,"low":0.24,"week52Low":0.2325,"pbRate":"-0.10","psRate":"48.92","week52High":13.3996,"institutionHeld":0,"latestPrice":0.2492,"eps":-13.601116,"divideRate":0,"volume":249438,"delay":0,"ttmEps":-13.601116,"open":0.24885,"prevYearClose":2.7616,"prevWeekClose":0.264,"prevMonthClose":0.302,"prevQuarterClose":0.62,"fiveDayClose":0.2685,"twentyDayClose":0.3943,"sixtyDayClose":0.792},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/EDVA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-19","symbol":"EDVA","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"盤後","type":"earning","dateTimestamp":1787112000000,"reportTimeType":"post","actualEps":-0.77}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"EDVA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"EDVA\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/EDVA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"EDVA","date":"2026-09-11","current":-0.018322,"percent":0.916667,"low":-0.155169,"twenty":-0.128751,"median":-0.109605,"eighty":-0.095565,"high":-0.090534,"avg":-0.111888,"sd":0.019546,"marketCap":1564655},"quantilePoints":[{"date":"2026-08-28","current":-0.118733,"twenty":-0.145082,"median":-0.136894,"eighty":-0.128751,"marketCap":2052006},{"date":"2026-09-04","current":-0.099624,"twenty":-0.136601,"median":-0.114948,"eighty":-0.105613,"marketCap":1721761},{"date":"2026-09-11","current":-0.090534,"twenty":-0.128751,"median":-0.109605,"eighty":-0.095565,"marketCap":1564655}],"updateTime":1789330525951},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":207433977,"employeeNum":2,"address":"1112 N. Flagler Drive,Fort Lauderdale,Florida,United States","zipCode":"33304","officePhone":"(954) 999-5446","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://endoviasciences.com","stockEarnings":[{"period":"1week","weight":-0.0561},{"period":"1month","weight":-0.3916},{"period":"3month","weight":-0.6668},{"period":"6month","weight":-0.8811},{"period":"1year","weight":-0.9648},{"period":"ytd","weight":-0.9098}],"compareEarnings":[{"period":"1week","weight":-0.0077},{"period":"1month","weight":-0.0106},{"period":"3month","weight":0.0304},{"period":"6month","weight":0.154},{"period":"1year","weight":0.1622},{"period":"ytd","weight":0.1208}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Endovia Health Sciences, Inc.於1992年9月3日在俄亥俄州註冊成立,並於2012年4月18日將住所變更為科羅拉多州。2021年11月8日,該公司將註冊州從科羅拉多州變更為內華達州。Endovia Health正在優先努力建立一個基於大麻素的多元化健康科學平台,專註於在製藥、獸醫和消費者健康市場獲取、開發和商業化基於大麻素的差異化健康技術。該公司的戰略結合了國際醫藥商業化、FDA監管的人類和獸醫開發以及基於大麻素的消費者健康和飲料機會。","yearOnYearQuotes":[{"month":1,"riseRate":0.833333,"avgChangeRate":0.547459},{"month":2,"riseRate":0.5,"avgChangeRate":0.069558},{"month":3,"riseRate":0.166667,"avgChangeRate":-0.275603},{"month":4,"riseRate":0.166667,"avgChangeRate":0.456475},{"month":5,"riseRate":0.166667,"avgChangeRate":-0.137897},{"month":6,"riseRate":0.333333,"avgChangeRate":0.008349},{"month":7,"riseRate":0.166667,"avgChangeRate":-0.17813},{"month":8,"riseRate":0.285714,"avgChangeRate":0.534255},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.145696},{"month":10,"riseRate":0,"avgChangeRate":-0.205596},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.096752},{"month":12,"riseRate":0.166667,"avgChangeRate":-0.181919}],"exchange":"AMEX","name":"Endovia Health Sciences Inc","nameEN":"Endovia Health Sciences Inc"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"EDVA\",market:\"US\",,,undefined,":{"directors":[{"name":"Brady Cobb","position":"Director and Interim Chief Executive Officer"},{"name":"Frederick William Caple","position":"Chairman of the Board and Director"},{"name":"Francis Knuettel II","position":"Director"},{"name":"Thomas Fore","position":"Director"}],"executives":[{"name":"Brady Cobb","position":"Director and Interim Chief Executive Officer"},{"name":"Michael Bondurant","position":"Interim Chief Operating Officer"},{"name":"Martin Scott","position":"Interim Chief Financial Officer"}]}}}